C
Astrana Health, Inc.
ASTH
$30.15
$0.9553.27%
C
Hold
3/7/2025Downgrade
Astrana Health, Inc. (ASTH) was downgraded to C- from C on 3/7/2025 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from $0.4 to $0.33, EBIT declined 5.46% from $30.07M to $28.43M, and total revenue declined 1.55% from $486.27M to $478.71M.
Astrana Health, Inc. (ASTH) was downgraded to C- from C on 3/7/2025 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from $0.4 to $0.33, EBIT declined 5.46% from $30.07M to $28.43M, and total revenue declined 1.55% from $486.27M to $478.71M.
C
Hold
5/18/2023Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C from C- on 5/18/2023 due to a significant increase in the growth index, total return index and valuation index. Earnings per share increased from -$0.06 to $0.31, EBIT increased 77.85% from $12.58M to $22.37M, and total revenue increased 14.63% from $294.21M to $337.24M.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C from C- on 5/18/2023 due to a significant increase in the growth index, total return index and valuation index. Earnings per share increased from -$0.06 to $0.31, EBIT increased 77.85% from $12.58M to $22.37M, and total revenue increased 14.63% from $294.21M to $337.24M.
C
Hold
3/3/2023Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C- from C on 3/3/2023 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.56 to -$0.06, net income declined 110.01% from $25.99M to -$2.6M, and EBIT declined 74.89% from $50.09M to $12.58M.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C- from C on 3/3/2023 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.56 to -$0.06, net income declined 110.01% from $25.99M to -$2.6M, and EBIT declined 74.89% from $50.09M to $12.58M.
C
Hold
8/12/2022Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 8/12/2022 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 62.47% from $24.04M to $9.02M, EBIT declined 41.31% from $26.21M to $15.38M, and earnings per share declined from $0.31 to $0.25.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 8/12/2022 due to a major decline in the growth index, solvency index and valuation index. Operating cash flow declined 62.47% from $24.04M to $9.02M, EBIT declined 41.31% from $26.21M to $15.38M, and earnings per share declined from $0.31 to $0.25.
C
Hold
7/25/2022Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 7/25/2022 due to an increase in the total return index.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 7/25/2022 due to an increase in the total return index.
C
Hold
7/8/2022Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 7/8/2022 due to a decline in the total return index and volatility index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 7/8/2022 due to a decline in the total return index and volatility index.
C
Hold
12/20/2021Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C+ from B- on 12/20/2021 due to a large decline in the total return index and volatility index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C+ from B- on 12/20/2021 due to a large decline in the total return index and volatility index.
B
Buy
12/14/2021Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to B- from B on 12/14/2021 due to a large decline in the total return index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to B- from B on 12/14/2021 due to a large decline in the total return index.
B
Buy
11/12/2021Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B from B- on 11/12/2021 due to an increase in the valuation index, solvency index and growth index. Earnings per share increased from $0.28 to $0.74, EBIT increased 153.29% from $20.99M to $53.16M, and operating cash flow increased 140.18% from $21.33M to $51.24M.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B from B- on 11/12/2021 due to an increase in the valuation index, solvency index and growth index. Earnings per share increased from $0.28 to $0.74, EBIT increased 153.29% from $20.99M to $53.16M, and operating cash flow increased 140.18% from $21.33M to $51.24M.
B
Buy
10/4/2021Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to B- from B on 10/4/2021 due to a decline in the volatility index and valuation index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to B- from B on 10/4/2021 due to a decline in the volatility index and valuation index.
B
Buy
8/10/2021Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B from B- on 8/10/2021 due to a noticeable increase in the total return index, solvency index and growth index. Operating cash flow increased 114.37% from $9.95M to $21.33M, debt to equity declined from 0.69 to 0.47, and the quick ratio increased from 2.85 to 3.55.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B from B- on 8/10/2021 due to a noticeable increase in the total return index, solvency index and growth index. Operating cash flow increased 114.37% from $9.95M to $21.33M, debt to equity declined from 0.69 to 0.47, and the quick ratio increased from 2.85 to 3.55.
B
Buy
7/14/2021Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to B- from B on 7/14/2021 due to a significant decline in the valuation index and total return index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to B- from B on 7/14/2021 due to a significant decline in the valuation index and total return index.
B
Buy
5/13/2021Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B from B- on 5/13/2021 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 482.62% from -$2.6M to $9.95M, earnings per share increased from $0.2654 to $0.3, and debt to equity declined from 0.74 to 0.69.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B from B- on 5/13/2021 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 482.62% from -$2.6M to $9.95M, earnings per share increased from $0.2654 to $0.3, and debt to equity declined from 0.74 to 0.69.
B
Buy
5/6/2021Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B- from C+ on 5/6/2021 due to a significant increase in the total return index and volatility index.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to B- from C+ on 5/6/2021 due to a significant increase in the total return index and volatility index.
C
Hold
1/25/2021Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 1/25/2021 due to an increase in the total return index and volatility index.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 1/25/2021 due to an increase in the total return index and volatility index.
C
Hold
12/14/2020Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 12/14/2020 due to a decline in the total return index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 12/14/2020 due to a decline in the total return index.
C
Hold
9/17/2020Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 9/17/2020 due to an increase in the volatility index and valuation index.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 9/17/2020 due to an increase in the volatility index and valuation index.
C
Hold
9/1/2020Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 9/1/2020 due to a decline in the valuation index, volatility index and solvency index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to C from C+ on 9/1/2020 due to a decline in the valuation index, volatility index and solvency index.
C
Hold
8/14/2020Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 8/14/2020 due to a major increase in the growth index, total return index and valuation index. Operating cash flow increased 335.32% from -$9.29M to $21.87M, EBIT increased 195.67% from $4.37M to $12.91M, and earnings per share increased from $0.11 to $0.19.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C+ from C on 8/14/2020 due to a major increase in the growth index, total return index and valuation index. Operating cash flow increased 335.32% from -$9.29M to $21.87M, EBIT increased 195.67% from $4.37M to $12.91M, and earnings per share increased from $0.11 to $0.19.
C
Hold
7/15/2020Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C from E+ on 7/15/2020 due to a noticeable increase in the efficiency index and total return index.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to C from E+ on 7/15/2020 due to a noticeable increase in the efficiency index and total return index.
E
Sell
6/15/2018Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to E+ from E on 6/15/2018 due to an increase in the volatility index.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to E+ from E on 6/15/2018 due to an increase in the volatility index.
E
Sell
6/5/2018Upgraded
Apollo Medical Holdings, Inc. (AMEH) was upgraded to E from E- on 6/5/2018 due to a significant increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 1.12 to 1.44, debt to equity declined from 0.04 to 0.03, and total capital increased 7.2% from $342.57M to $367.23M.
Apollo Medical Holdings, Inc. (AMEH) was upgraded to E from E- on 6/5/2018 due to a significant increase in the valuation index, solvency index and efficiency index. The quick ratio increased from 1.12 to 1.44, debt to equity declined from 0.04 to 0.03, and total capital increased 7.2% from $342.57M to $367.23M.
E
Sell
3/16/2018Downgrade
Apollo Medical Holdings, Inc. (AMEH) was downgraded to E- from E on 3/16/2018 due to a decline in the volatility index.
Apollo Medical Holdings, Inc. (AMEH) was downgraded to E- from E on 3/16/2018 due to a decline in the volatility index.
E
Sell
3/8/2018None
Astrana Health, Inc. (ASTH) was downgraded to E from U on 03/08/2018.
Astrana Health, Inc. (ASTH) was downgraded to E from U on 03/08/2018.
NASDAQ
03/14/2025 11:36AM Eastern
Quotes delayed